This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Asthma
  • /
  • Reslizumab in patients with inadequately controlle...

Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils.

Read time: 1 mins
Published:1st Apr 2017
Author: Brusselle G, Germinaro M, Weiss S, Zangrilli J.
Availability: Free full text
Ref.:Pulm Pharmacol Ther. 2017;43:39-45
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest